NIH-funded research NIH-funded research

Directly reprogramming heart cells to become heart cells to repair damage

Official title: Post-transcriptional mechanisms of direct cardiac reprogramming

Funded at Ohio State University · NIH-11468163 · Data updated 2026-11-12

A study at Ohio State University aims to help the heart repair itself after a heart attack by turning supporting heart cells into cardiomyocyte-like cells using specific genetic instructions.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionOhio State University
NIH-funded
Lab location1 site (Columbus, UNITED STATES)
Project startJuly 10, 2026
Project endMay 31, 2029
Funding year2026
Award (this year)$249,000
NIH project number4R00HL175039-03
Project IDNIH-11468163 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with a history of myocardial infarction or heart damage who would benefit from therapies aiming to regenerate heart muscle.

Less likely to help

Patients without heart tissue damage or those not suitable for cell-based therapeutic approaches may not benefit from this research.

What this research studies

Researchers will focus on how post-transcriptional processes influence direct reprogramming of cardiac fibroblasts into induced cardiomyocyte-like cells. The work builds on prior findings about RNA-binding proteins and m6A RNA modifications to understand barriers to reprogramming and to identify molecular targets that improve conversion efficiency. The program leverages genome-wide profiling and mechanistic experiments to map how post-transcriptional regulators affect heart cell identity in adult human cells. The ultimate goal is to advance strategies that could restore heart muscle after injury in patients with myocardial infarction.

Why it matters

Potential benefit: If successful, this research could inform therapies that regenerate heart tissue after a heart attack, potentially improving heart function and reducing heart failure risk.

How similar studies have gone: Previous studies show that manipulating reprogramming pathways can convert supporting heart cells into heart-like cells, with promising but early results.

Where this research is happening

  • Ohio State University
    Columbus, United States
    Active

Researchers

  • Principal investigator: Xie, Yifang — Ohio State University
  • Study coordinator: Xie, Yifang

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.